血糖状态与择期手术风险:临床识别的高血糖与仅糖尿病诊断在全国队列中的比较
该回顾性队列研究基于美国全国住院患者样本(2016-2022),纳入接受择期关节置换、腰椎融合、胆囊切除、结肠切除、心脏手术或子宫切除的成人,按血糖状态分为无糖尿病、糖尿病无高血糖和糖尿病伴高血糖。主要复合终点为死亡、急性肾损伤、脓毒症、心梗、缺血性卒中或静脉血栓栓塞。结果显示,糖尿病无高血糖仅轻度增加风险(aOR 1.13),而糖尿病伴高血糖风险显著升高(aOR 2.00),提示血糖状态比单纯糖尿病诊断更能指导择期手术风险分层。
要点
- 糖尿病无临床高血糖者围术期风险轻度升高,aOR 1.13,NNT 183。
- 糖尿病伴临床高血糖者主要不良事件风险显著增加,aOR 2.00,NNT 26。
- 择期手术风险评估应关注血糖状态而非仅糖尿病诊断。
核心结论
- 糖尿病无临床识别的高血糖是较弱的危险因素,而临床识别的高血糖则提示围术期风险显著增高。
- 血糖状态可能比单纯糖尿病诊断更好地指导择期手术风险分层。
研究设计与样本
- 回顾性队列研究,使用美国全国住院患者样本(National Inpatient Sample)2016至2022年数据。
- 纳入接受择期关节置换、腰椎融合、胆囊切除、结肠切除、心脏手术或子宫切除的成人。
- 按ICD-10临床修改编码分为无糖尿病、糖尿病无高血糖和糖尿病伴高血糖三组。
- 主要终点为复合主要不良事件(死亡、急性肾损伤、脓毒症、心梗、缺血性卒中或静脉血栓栓塞)。
- 采用调查加权多因素logistic回归,调整人口学、支付方、手术类型、年份、医院特征和Elixhauser合并症。
主要发现
- 调整后主要不良事件概率:无糖尿病5.31%,糖尿病无高血糖5.85%,糖尿病伴高血糖9.16%。
- 糖尿病无高血糖与主要不良事件轻度增加相关(aOR 1.13;95% CI 1.11-1.15;绝对风险差0.55%;NNT 183),在17项手术危险因素中排第16位。
- 糖尿病伴高血糖与主要不良事件显著增加相关(aOR 2.00;95% CI 1.94-2.05;绝对风险差3.85%;NNT 26)。
临床怎么用
- 对于仅诊断为糖尿病但无临床高血糖的择期手术患者,无需仅因糖尿病诊断而推迟手术。
- 应识别并积极管理临床高血糖,以降低择期手术围术期主要不良事件风险。
- 在术前风险评估中,将血糖状态纳入考量,优于仅依赖糖尿病诊断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diabetes affects 20% to 25% of surgical patients, but whether elective surgery should be deferred for patients with diabetes absent clinically recognized hyperglycemia remains unclear. We evaluated perioperative risk by glycemic status in adults undergoing elective surgery. STUDY DESIGN: Retrospective cohort study of the National Inpatient Sample, 2016 to 2022. Adults undergoing elective joint arthroplasty, lumbar spine fusion, cholecystectomy, colectomy, cardiac surgery, or hysterectomy were classified as no diabetes, diabetes without hyperglycemia, or diabetes with hyperglycemia using ICD-10 Clinical Modification codes. The primary endpoint was composite major adverse events (mortality, acute kidney injury, sepsis, MI, ischemic stroke, or venous thromboembolism). Survey-weighted multivariable logistic regression adjusted for demographics, payer, procedure type, year, hospital characteristics, and Elixhauser comorbidities. RESULTS: Among 2,104,338 hospitalizations (~10.5 million weighted), 1,641,797 (78.0%) had no diabetes, 398,095 (18.9%) had diabetes without hyperglycemia, and 64,446 (3.1%) had diabetes with hyperglycemia. Adjusted major adverse event probability was 5.31% for no diabetes, 5.85% for diabetes without hyperglycemia, and 9.16% for diabetes with hyperglycemia. Diabetes without hyperglycemia was associated with modestly increased odds of major adverse events (adjusted odds ratio 1.13; 95% CI 1.11 to 1.15; absolute risk difference 0.55%; number needed to harm 183) and ranked 16th of 17 surgical risk factors examined. Diabetes with hyperglycemia was associated with substantially higher risk (adjusted odds ratio 2.00; 95% CI 1.94 to 2.05; absolute risk difference 3.85%; number needed to harm 26). CONCLUSIONS: Diabetes without clinically recognized hyperglycemia was a comparatively weak risk factor, whereas clinically recognized hyperglycemia identified a substantially higher perioperative risk. These findings suggest glycemic status may better inform elective surgical risk stratification than diabetes diagnosis alone.
引用
- Kim S, Saad B, Bracamontes G, et al. Glycemic Status and Elective Surgery Risk: Clinically Recognized Hyperglycemia vs Diabetes Diagnosis Alone in a National Cohort. J Am Coll Surg. 2026. PMID: 41989025. doi:10.1097/XCS.0000000000001981
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。